Tomas Neilan
托马斯·尼兰
MD, MMSc
Director, Cardio-Oncology Program; Associate Professor of Medicine肿瘤心脏病学项目主任，副教授
👥Biography 个人简介
Director of the Cardio-Oncology Program at Massachusetts General Hospital, Dr. Neilan is a global leader in cardiac MRI applications for oncology and in characterizing immune checkpoint inhibitor myocarditis. His research bridges advanced imaging and immunology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Cardiac MRI in Oncology
Pioneered cardiac MRI protocols for detecting subclinical cardiotoxicity in cancer therapy, establishing imaging standards.
ICI Myocarditis Outcomes Research
Co-led landmark studies characterizing clinical course and outcomes of immune checkpoint inhibitor-associated myocarditis.
MGH Cardio-Oncology Program
Developed MGH Cardio-Oncology Program with emphasis on imaging-guided surveillance and multidisciplinary collaboration.
Representative Works 代表性著作
Myocarditis in Patients Treated with Immune Checkpoint Inhibitors
Journal of the American College of Cardiology (2018)
Characterized clinical course and outcomes of ICI-associated myocarditis.
Cardiac MRI for Detection of Cancer Therapy Cardiotoxicity
JACC: Cardiovascular Imaging (2020)
Established cardiac MRI as a standard surveillance modality in cardio-oncology.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bonnie Ky
Penn Medicine / University of Pennsylvania
Javid Moslehi
University of California San Francisco (UCSF)
Richard Steingart
Memorial Sloan Kettering Cancer Center
Daniel Lenihan
International CardiOncology Society (ICOS)
关注 托马斯·尼兰 的研究动态
Follow Tomas Neilan's research updates
留下邮箱，当我们发布与 Tomas Neilan（Massachusetts General Hospital / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment